美女免费一级视频在线观看

Klick Health is expanding its presence in the market access space with the acquisition of Peregrine Market Access. 

The 2024 MM+M Agency 100 honoree announced the transaction Tuesday morning. Financial terms were not disclosed. 

The healthcare communications firm welcomed Peregrine president and managing partner John Guarino and the rest of the team to Klick, commending them for their dedicated work in the healthcare client solutions and market access space. 

Guarino, who founded Peregrine in 2016, built out the Saratoga Springs-based company with the aim of helping pharma clients demonstrate the value of their products to health insurers and government agencies in order to widen the access of high-quality medicines for patients. 

After gaining national recognition on the Inc. 5000 list as one of the fastest growing companies two years in a row in 2021 and 2022, Guarino’s thought shifted to scaling up. 

Still, he had no intention of selling the business — that was until he had a conversation with Klick Group’s Commercial Solutions president Brian Fox. 

“After chatting with him, I realized that we were really a good fit,” Guarino said.

An industry veteran of more than 30 years, Guarino said he found Klick’s portfolio compelling and was enamored by its executive team. 

“It’s a company run by people who care,” he added. 

He said the acquisition is a “natural pathway” for Klick Health to pivot to market access and target every point in the life sciences lifecycle. He added that it is helpful for clients to understand the math and clinical cost impact of their products on patients.

As for Klick, chief medical officer Holly Henry said the agency was attracted to Peregrine for its similar culture and values.

“We are a people-first organization and they are a people-first organization” she said. “They care about client and patient communications, and together we are focused on getting patients the products they need.” 

The acquisition will boost Klick’s healthcare service portfolio beyond its current capabilities. In addition to its slew of AI and omnichannel marketing services, Klick will now be able to offer more market access services for pharma clients. 

Additionally, this builds on the hiring of Ellen Cappellino as executive director of value, access and reimbursement in October 2023, which bolstered Klick’s ambitions in the space.

Plus, by being folded into Klick, Peregrine will be exposed to a whole new set of clients, providing them the opportunity to expand their reach. 

Henry predicted the acquisition will usher in better services, provide clients with a more comprehensive understanding of market access as well as connections to speciality business groups. 

This area of service is valuable for clients in the ever-changing landscape of rules and regulations around new healthcare products. 

Looking forward, Guarino noted that it’s important that pharma companies understand what strategies work when going forward with a commercialization plan. 

He cautioned that drugmakers are not going to have a 20-year run of blockbuster drugs like they used to, noting that things move much faster now, so understanding the value of a product before its launch is important.

Klick Health’s co-founder and chairman Leerom Segal shared similar sentiments about the challenges facing the industry in 2025, though he also noted that both companies are committed to serving clients in the best way possible. 

“Both Peregrine and Klick are passionate about helping clients get innovative therapies to the patients who need them,” he said. “We believe this will be a greater challenge for patients in the future, which makes an investment in this area so valuable.”